Boston Scientific inaugurates new offices at Dubai Science Park


Boston Scientific, a global medical technology company, has opened new offices in Dubai Science Park (DSP), the leading science-focused community part of TECOM Group, to meet the growing needs of patients in the Middle East.

The new offices will be the third in the Middle East, adding to their seven offices in Eurasia, Southeast Europe, and Africa, which cover 97 countries and employ over 500 people. Boston Scientific UAE’s expansion aims to address the significant increase in demand for medical devices in the region, which is expected to reach US$21,802.3 million in 2027, according to Business Market Insights.

Commenting on the launch of the new offices, Marwan Abdulaziz Janahi, Managing Director of Dubai Science Park, said: “Dubai is on track to becoming a global healthcare destination with state-of-the-art infrastructure and government support, and brands like Boston Scientific play an essential role in driving research, investment and insights. 

Ins 1 - Boston Scientific - Dubai Science Park - offices - TECOM Group - TechxmediaIns 1 - Boston Scientific - Dubai Science Park - offices - TECOM Group - Techxmedia

“We are delighted to be a part of Boston Scientific’s growth story since they joined our ecosystem in 2018, and deeply share their mission to improve the lives of patients across the region. We will continue enhancing our enabling ecosystem and enrich the opportunities available to our existing and potential business partners in our mission to advance our national healthcare goals.”  

Eric Thepaut, Executive Vice President and President EMEA at Boston Scientific, said: “At Boston Scientific we aim at transforming lives globally through innovative medical solutions. This is why investments in the Middle East & North Africa (MENA) region are so significant and far-reaching. Strengthening our presence in the region will enable our teams to operate more efficiently and raise awareness of our innovative solutions for a wide range of therapy areas”.

“The Growth Emerging Markets (GEM) is of strategic priority to Boston Scientific,” said Tarek El Rahbani, Senior Regional Director Middle East & Africa. “This is the part of the world with huge growth potential, there are millions of patients in need of our innovative therapies. Our mission reminds us that we are a company dedicated to transforming lives through innovative medical solutions that improve the health of patients around the world. Our expansion efforts in the region including the new office in Dubai helps us to fulfill this mission. We can take enormous pride that we are in the business of “transforming lives”.